Abstract
Lipopolysaccharide (LPS), a cell surface component of Gram-negative bacteria, and its active principle, lipid A, have immunostimulatory properties and thus potential to act as adjuvants. However, canonical LPS acts as an endotoxin by hyperstimulating the immune response. Therefore, it is necessary to structurally modify LPS and lipid A to minimize toxicity while maintaining adjuvant effects for use as vaccine adjuvants. Various studies have focused on the chemical synthetic method of lipid As and their structure-activity relationship, which are reviewed in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kusumoto S, Fukase K, Shiba T (2010) Key structures of bacterial peptidoglycan and lipopolysaccharide triggering the innate immune system of higher animals: chemical synthesis and functional studies. Proc Jpn Acad Ser B Phys Biol Sci 86(4):322–337
Wei MQ, Mengesha A, Good D, Anne J (2008) Bacterial targeted tumour therapy-dawn of a new era. Cancer Lett 259(1):16–27. https://doi.org/10.1016/j.canlet.2007.10.034
Coley WB (1991) The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res 262:3–11
Leroux-Roels G (2010) Unmet needs in modern vaccinology: adjuvants to improve the immune response. Vaccine 28(Suppl 3):C25–C36. https://doi.org/10.1016/j.vaccine.2010.07.021
E.T. Rietschel OW (1999) Endotoxin: historical perspectives. In Endotoxin in health and disease
Imoto M, Kusumoto S, Shiba T, Naoki H, Iwashita T, Rietschel ET, Wollenweber HW, Galanos C, Luderitz O (1983) Chemical-structure of Escherichia-Coli lipid-a – linkage site of acyl-groups in the disaccharide backbone. Tetrahedron Lett 24(37):4017–4020. https://doi.org/10.1016/S0040-4039(00)88251-9
Imoto M, Kusumoto S, Shiba T, Rietschel ET, Galanos C, Luederitz O (1985) Chemical structure of Escherichia coli lipid a. Tetrahedron Lett 26(7):907–908
Imoto M, Yoshimura H, Shimamoto T, Sakaguchi N, Kusumoto S, Shiba T (1987) Total synthesis of Escherichia coli lipid a, the endotoxically active principle of cell-surface lipopolysaccharide. Bull Chem Soc Jpn 60(6):2205–2214
Molinaro A, Holst O, Di Lorenzo F, Callaghan M, Nurisso A, D'Errico G, Zamyatina A, Peri F, Berisio R, Jerala R, Jimenez-Barbero J, Silipo A, Martin-Santamaria S (2015) Chemistry of lipid a: at the heart of innate immunity. Chemistry 21(2):500–519. https://doi.org/10.1002/chem.201403923
Di Lorenzo F, Duda KA, Lanzetta R, Silipo A, De Castro C, Molinaro A (2021) A journey from structure to function of bacterial lipopolysaccharides. Chem Rev. https://doi.org/10.1021/acs.chemrev.0c01321
Shimoyama A, Fukase K (2021) Lipid A-mediated bacterial-host chemical ecology: synthetic research of bacterial lipid as and their development as adjuvants. Molecules 26(20). https://doi.org/10.3390/molecules26206294
Flad HD, Loppnow H, Feist W, Wang MH, Brade H, Kusumoto S, Rietschel ET, Ulmer AJ (1989) Interleukin 1 and tumor necrosis factor: studies on the induction by lipopolysaccharide partial structures. Lymphokine Res 8(3):235–238
Wang MH, Feist W, Herzbeck H, Brade H, Kusumoto S, Rietschel ET, Flad HD, Ulmer AJ (1990) Suppressive effect of lipid A partial structures on lipopolysaccharide or lipid A-induced release of interleukin 1 by human monocytes. FEMS Microbiol Immunol 2(3):179–185. https://doi.org/10.1111/j.1574-6968.1990.tb03517.x
Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86(6):973–983. https://doi.org/10.1016/s0092-8674(00)80172-5
Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388(6640):394–397. https://doi.org/10.1038/41131
Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282(5396):2085–2088. https://doi.org/10.1126/science.282.5396.2085
Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5):373–384. https://doi.org/10.1038/ni.1863
Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189(11):1777–1782. https://doi.org/10.1084/jem.189.11.1777
Akashi S, Nagai Y, Ogata H, Oikawa M, Fukase K, Kusumoto S, Kawasaki K, Nishijima M, Hayashi S, Kimoto M, Miyake K (2001) Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 13(12):1595–1599. https://doi.org/10.1093/intimm/13.12.1595
Ohto U, Fukase K, Miyake K, Satow Y (2007) Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316(5831):1632–1634. https://doi.org/10.1126/science.1139111
Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, Lee JO (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130(5):906–917. https://doi.org/10.1016/j.cell.2007.08.002
Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458(7242):1191–1195. https://doi.org/10.1038/nature07830
Ohto U, Fukase K, Miyake K, Shimizu T (2012) Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc Natl Acad Sci U S A 109(19):7421–7426. https://doi.org/10.1073/pnas.1201193109
Brade L, Brandenburg K, Kuhn HM, Kusumoto S, Macher I, Rietschel ET, Brade H (1987) The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immun 55(11):2636–2644
Tanimura N, Saitoh S, Ohto U, Akashi-Takamura S, Fujimoto Y, Fukase K, Shimizu T, Miyake K (2014) The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane. Int Immunol 26(6):307–314. https://doi.org/10.1093/intimm/dxt071
Fujimoto Y, Shimoyama A, Saeki A, Kitayama N, Kasamatsu C, Tsutsui H, Fukase K (2013) Innate immunomodulation by lipophilic termini of lipopolysaccharide; synthesis of lipid As from Porphyromonas gingivalis and other bacteria and their immunomodulative responses. Mol BioSyst 9(5):987–996. https://doi.org/10.1039/c3mb25477a
Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC (2007) The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316(5831):1628–1632. https://doi.org/10.1126/science.1138963
Yoshizaki H, Fukuda N, Sato K, Oikawa M, Fukase K, Suda Y, Kusumoto S (2001) First total synthesis of the re-type lipopolysaccharide this work was supported by the research for the future program (No. 97L00502) from the Japan Society for the Promotion of Science. H.Y. is grateful for a JSPS Research Fellowship for Young Scientists (No. 1241) from the Japan Society for the Promotion of Science. The authors are grateful to Mr. Seiji Adachi for his skillful measurement of NMR spectra. Angew Chem Int Ed Engl 40(8):1475–1480
Zhang Y, Gaekwad J, Wolfert MA, Boons GJ (2008) Innate immune responses of synthetic lipid A derivatives of Neisseria meningitidis. Chemistry 14(2):558–569. https://doi.org/10.1002/chem.200701165
Shimoyama A, Saeki A, Tanimura N, Tsutsui H, Miyake K, Suda Y, Fujimoto Y, Fukase K (2011) Chemical synthesis of Helicobacter pylori lipopolysaccharide partial structures and their selective proinflammatory responses. Chemistry 17(51):14464–14474. https://doi.org/10.1002/chem.201003581
Hynes SO, Ferris JA, Szponar B, Wadstrom T, Fox JG, O'Rourke J, Larsson L, Yaquian E, Ljungh A, Clyne M, Andersen LP, Moran AP (2004) Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic helicobacters. Helicobacter 9(4):313–323. https://doi.org/10.1111/j.1083-4389.2004.00237.x
Nielsen H, Birkholz S, Andersen LP, Moran AP (1994) Neutrophil activation by Helicobacter pylori lipopolysaccharides. J Infect Dis 170(1):135–139
Perez-Perez GI, Shepherd VL, Morrow JD, Blaser MJ (1995) Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun 63(4):1183–1187
Danesh J, Wong Y, Ward M, Muir J (1999) Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease. Heart 81(3):245–247
Triantafilou M, Gamper FG, Lepper PM, Mouratis MA, Schumann C, Harokopakis E, Schifferle RE, Hajishengallis G, Triantafilou K (2007) Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell Microbiol 9(8):2030–2039. https://doi.org/10.1111/j.1462-5822.2007.00935.x
Imamura M, Tsutsui H, Yasuda K, Uchiyama R, Yumikura-Futatsugi S, Mitani K, Hayashi S, Akira S, Taniguchi S, Van Rooijen N, Tschopp J, Yamamoto T, Fujimoto J, Nakanishi K (2009) Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol 51(2):333–341. https://doi.org/10.1016/j.jhep.2009.03.027
Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, Nunez G (2007) Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26(4):433–443. https://doi.org/10.1016/j.immuni.2007.03.008
Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L, Shao F (2014) Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514(7521):187–192. https://doi.org/10.1038/nature13683
Obata T, Goto Y, Kunisawa J, Sato S, Sakamoto M, Setoyama H, Matsuki T, Nonaka K, Shibata N, Gohda M, Kagiyama Y, Nochi T, Yuki Y, Fukuyama Y, Mukai A, Shinzaki S, Fujihashi K, Sasakawa C, Iijima H, Goto M, Umesaki Y, Benno Y, Kiyono H (2010) Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proc Natl Acad Sci U S A 107(16):7419–7424. https://doi.org/10.1073/pnas.1001061107
Kunisawa J, Kiyono H (2012) Alcaligenes is commensal bacteria habituating in the gut-associated lymphoid tissue for the regulation of intestinal IgA responses. Front Immunol 3:65. https://doi.org/10.3389/fimmu.2012.00065
Kunisawa J, Nochi T, Kiyono H (2008) Immunological commonalities and distinctions between airway and digestive immunity. Trends Immunol 29(11):505–513. https://doi.org/10.1016/j.it.2008.07.008
Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K (2010) Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol 28:243–273. https://doi.org/10.1146/annurev-immunol-030409-101314
Fung TC, Bessman NJ, Hepworth MR, Kumar N, Shibata N, Kobuley D, Wang K, Ziegler CGK, Goc J, Shima T, Umesaki Y, Sartor RB, Sullivan KV, Lawley TD, Kunisawa J, Kiyono H, Sonnenberg GF (2016) Lymphoid-tissue-resident commensal bacteria promote members of the IL-10 cytokine family to establish mutualism. Immunity 44(3):634–646. https://doi.org/10.1016/j.immuni.2016.02.019
Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, Tardif MR, Sathaliyawala T, Kubota M, Farber DL, Collman RG, Shaked A, Fouser LA, Weiner DB, Tessier PA, Friedman JR, Kiyono H, Bushman FD, Chang KM, Artis D (2012) Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336(6086):1321–1325. https://doi.org/10.1126/science.1222551
Shibata N, Kunisawa J, Hosomi K, Fujimoto Y, Mizote K, Kitayama N, Shimoyama A, Mimuro H, Sato S, Kishishita N, Ishii KJ, Fukase K, Kiyono H (2018) Lymphoid tissue-resident Alcaligenes LPS induces IgA production without excessive inflammatory responses via weak TLR4 agonist activity. Mucosal Immunol 11(3):693–702. https://doi.org/10.1038/mi.2017.103
Shimoyama A, Di Lorenzo F, Yamaura H, Mizote K, Palmigiano A, Pither MD, Speciale I, Uto T, Masui S, Sturiale L, Garozzo D, Hosomi K, Shibata N, Kabayama K, Fujimoto Y, Silipo A, Kunisawa J, Kiyono H, Molinaro A, Fukase K (2021) Lipopolysaccharide from gut-associated lymphoid tissue-resident Alcaligenes faecalis: complete structure determination and chemical synthesis of its lipid As. Angew Chem Int Ed Engl 60:10023. https://doi.org/10.1002/anie.202012374
Hosomi K, Shibata N, Shimoyama A, Uto T, Nagatake T, Tojima Y, Nishino T, Takeyama H, Fukase K, Kiyono H, Kunisawa J (2020) Lymphoid tissue-resident Alcaligenes establish an intracellular symbiotic environment by creating a unique energy shift in dendritic cells. Front Microbiol 11:561005. https://doi.org/10.3389/fmicb.2020.561005
Hexa-acylated A. faecalis lipid A (Hexa-AfLA) is commercially available: https://www.peptide.co.jp/catalog/f-cat?k_code=24018-s
Yoshii K, Hosomi K, Shimoyama A, Wang Y, Yamaura H, Nagatake T, Suzuki H, Lan H, Kiyono H, Fukase K, Kunisawa J (2020) Chemically synthesized Alcaligenes lipid A shows a potent and safe nasal vaccine adjuvant activity for the induction of Streptococcus pneumoniae-specific IgA and Th17 mediated protective immunity. Microorganisms 8(8). https://doi.org/10.3390/microorganisms8081102
Wang Y, Hosomi K, Shimoyama A, Yoshii K, Yamaura H, Nagatake T, Nishino T, Kiyono H, Fukase K, Kunisawa J (2020) Adjuvant activity of synthetic lipid a of Alcaligenes, a gut-associated lymphoid tissue-resident commensal bacterium, to augment antigen-specific IgG and Th17 responses in systemic vaccine. Vaccines (Basel) 8(3). https://doi.org/10.3390/vaccines8030395
Martin M, Michalek SM, Katz J (2003) Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect Immun 71(5):2498–2507
Shimoyama A, Saeki A, Tanimura N, Tsutsui H, Miyake K, Suda Y, Fujimoto Y, Fukase K (2011) Chemical synthesis of Helicobacter pylori lipopolysaccharide partial structures and their selective proinflammatory responses. Chem Eur J 17(51):14464–14474. https://doi.org/10.1002/chem.201003581
Fujimoto Y, Shimoyama A, Suda Y, Fukase K (2012) Synthesis and immunomodulatory activities of Helicobacter pylori lipophilic terminus of lipopolysaccharide including lipid A. Carbohydr Res 356:37–43. https://doi.org/10.1016/j.carres.2012.03.013
Fukase K, Fukase Y, Oikawa M, Liu WC, Suda Y, Kusumoto S (1998) Divergent synthesis and biological activities of lipid A analogues of shorter acyl chains. Tetrahedron 54(16):4033–4050. https://doi.org/10.1016/S0040-4020(98)00133-1
Shiina I, Ibuka R, Kubota M (2002) A new condensation reaction for the synthesis of carboxylic esters from nearly equimolar amounts of carboxylic acids and alcohols using 2-methyl-6-nitrobenzoic anhydride. Chem Lett 3:286–287. https://doi.org/10.1246/Cl.2002.286
Baudry D, Ephritikhine M, Felkin H (1978) Isomerization of allyl ethers catalyzed by cationic iridium complex [Ir(Cyclo-Octa-1,5-Diene)(Pmeph2)2]Pf6 – highly Stereoselective route to trans-Propenyl ethers. J Chem Soc Chem Commun 16:694–695. https://doi.org/10.1039/C39780000694
Murray RW, Jeyaraman R (1985) Dioxiranes – synthesis and reactions of Methyldioxiranes. J Org Chem 50(16):2847–2853. https://doi.org/10.1021/Jo00216a007
Mueller M, Lindner B, Kusumoto S, Fukase K, Schromm AB, Seydel U (2004) Aggregates are the biologically active units of endotoxin. J Biol Chem 279(25):26307–26313. https://doi.org/10.1074/jbc.M401231200
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Shimoyama, A., Fukase, K. (2023). Chemical Synthesis and Immunomodulatory Functions of Bacterial Lipid As. In: Kabayama, K., Inokuchi, Ji. (eds) Glycolipids. Methods in Molecular Biology, vol 2613. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2910-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2910-9_4
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2909-3
Online ISBN: 978-1-0716-2910-9
eBook Packages: Springer Protocols